A Randomized, Comparative Pilot Study of Azithromycin Versus Benzathine Penicillin G for Treatment of Early Syphilis
Authors:
- Edward W. HookEdward W. Hook
- David H. MartinDMDavid H. Martin
- Joan StephensJSJoan Stephens
- Barbara S. SmithBSBarbara S. Smith
- Kim SmithKSKim Smith
- 1 August 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 29 (8) , 486-490
Abstract
Penicillin is the only medication currently recommended for treatment of early syphilis in non-penicillin-allergic patients. Preliminary data suggest that azithromycin may be effective for syphilis therapy. This was a randomized, comparative pilot study of intramuscular injections of benzathine penicillin G and two oral azithromycin regimens for treatment of syphilis. We randomly assigned patients with early syphilis to treatment with either intramuscular injections of 2.4 million units of benzathine penicillin G or azithromycin administered orally, either as a single 2.0-g dose or as two 2.0-g doses given 1 week apart. Serological response to therapy was evaluated at 3, 6, 9, and 12 months following therapy. Participants whose rapid plasma reagin (RPR) test became nonreactive or whose RPR titer decreased > or =2 dilutions were classified as responding to therapy. When serological tests did not show a response to therapy, the treatment was classified as a failure if RPR titers increased > or =2 dilutions. Nonresponders were those whose serologic titers remained within +/-1 dilution of the initial RPR titer. Cumulative response rates were as follows: benzathine penicillin G, 86% (12 of 14); azithromycin, 2.0-g single dose, 94% (16 of 17); and azithromycin, two 2.0-g doses given 1 week apart, 83% (24 of 29). Therapy failed for one patient treated with benzathine penicillin and one patient treated with the two-dose azithromycin regimen, whereas in six patients the clinical manifestations of infection resolved but there was no serological response. Oral therapy with 2.0 g of azithromycin as a single dose or as two doses 1 week apart is a promising alternative to therapy with benzathine penicillin G for syphilis and should be studied further.Keywords
This publication has 13 references indexed in Scilit:
- Azithromycin Compared with Penicillin G Benzathine for Treatment of Incubating SyphilisAnnals of Internal Medicine, 1999
- Elimination of Syphilis in the United StatesScience, 1998
- Is elimination of endemic syphilis transmission a realistic goal for the USA?The Lancet, 1998
- Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study1995
- Pilot Study of Azithromycin for Treatment of Primary and Secondary SyphilisClinical Infectious Diseases, 1994
- Multicenter Trial of Single-Dose Azithromycin vs. Ceftriaxone in the Treatment of Uncomplicated GonorrheaSexually Transmitted Diseases, 1994
- Clinical experience with penicillin skin testing in a large inner-city STD clinic1993
- A Controlled Trial of a Single Dose of Azithromycin for the Treatment of Chlamydial Urethritis and CervicitisNew England Journal of Medicine, 1992
- Acquired Syphilis in AdultsNew England Journal of Medicine, 1992
- Lomefloxacin-induced modification of the kinetics of growth of Gram-negative bacteria and susceptibility to phagocytic killing by human neutrophilsJournal of Antimicrobial Chemotherapy, 1990